NDC 51662-1239-2 - NALOXONE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1239
- Requested NDC
- 51662-1239-2
- Package NDCs from labels
- 51662-1239-1, 51662-1239-2, 51662-1239-3
- Manufacturer
- HF Acquisition Co. LLC, DBA HealthFirst
- Effective date
- 2024-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE - HF Acquisition Co. LLC, DBA HealthFirst | HF Acquisition Co. LLC, DBA HealthFirst | 2024-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1239-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-0c01-f424-e053-dadaa90a57ce | NALOXONE HYDROCHLORIDE INJ., USP (1mg/mL) 2mL SYR |
| 51662-1239-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0c01-f424-e053-dadaa90a57ce | NALOXONE HYDROCHLORIDE INJ., USP (1mg/mL) 2mL SYR |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1239-1 | NALOXONE HYDROCHLORIDE | 2 mL in 1 SYRINGE, PLASTIC | INJECTION | 2 | 6 | |
| 51662-1239-1 | NALOXONE HYDROCHLORIDE | 1 in 1 BOX | INJECTION | 1 | 6 | |
| 51662-1239-2 | NALOXONE HYDROCHLORIDE | 1 mL in 1 POUCH | INJECTION | 1 | 6 | |
| 51662-1239-3 | NALOXONE HYDROCHLORIDE | 10 in 1 CASE | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1239 | NALOXONE HYDROCHLORIDE INJECTION [HF ACQUISITION CO. LLC, DBA HEALTHFIRST] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240126_74fc593e-ed47-efae-e053-2991aa0a5997.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Mylan Institutional LLC | f0932877-1f3b-4d5e-82d2-dd6c53db4730 | 2020-08-17 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALXONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 8cc25cf1-008c-4808-baec-49f35a887fae | 2020-03-20 | Warnings, Adverse reactions | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.